Bio industry urges US to exempt South Korea from proposed pharmaceutical tariffs

Bio industry urges US to exempt South Korea from proposed pharmaceutical tariffs

The Korea Biotechnology Industry Organization (KBIO) said Wednesday it has requested the United States to exempt Korea from the Donald Trump administration's plan to impose tariffs on pharmaceutical i...

S. Korea’s bio industry urges US to exempt it from proposed...

Last Updated on May 7, 2025 by Team THIP Seoul, May 7 (IANS) The Korea Biotechnology Industry Organization (KBIO) on Wednesday said it has requested the US to exempt South Korea from the Donald Trump administration’s plan to impose tariffs on pharmaceutical imports. KBIO said it submitted such an opinion formally to the US Department […] The post S. Korea’s bio industry urges US to exempt it from proposed pharmaceutical tariffs appeared first on…

S. Korea’s bio industry urges US to exempt it from proposed pharmaceutical tariffs

Seoul, May 7 (SocialNews.XYZ) The Korea Biotechnology Industry Organization (KBIO) on Wednesday said it has requested the US to exempt South Korea from the Donald Trump administration's plan to impose tariffs on pharmaceutical imports. KBIO said it submitted such an opinion formally to the US Department of Commerce on Tuesday (US time) regarding an ongoing investigation under Section 232 of the Trade Expansion Act, which is examining the nationa…

Comments to the Bureau of Industry and Security Regarding Its Section 232 Investigation of Pharmaceutical Imports

ITIF’s comments cover issues related to demand for pharmaceuticals; domestic production capacity; the role of foreign supply chains; the concentration of suppliers; the impact of foreign subsidies; the impact of artificially suppressed prices; and other trade considerations.

AHA comments on national security investigation of pharmaceutical imports

AHA today submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports. The AHA urged the administration to maintain tariff exceptions, particularly for products already experiencing shortages and for countries that produce a significant portion of the U.S. market supply of pharmaceuticals and pharmaceutical ingredients.“The lives of patients often de…